Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rifaximin Associated With Classic Triple Therapy (Inhibitor of Proton Pump, Amoxicillin and Clarithromycin) for the Eradication of Helicobacter Pylori Infection

NCT03124199 is registered in ClinicalTrials.gov with Fundación de Investigación Biomédica - Hospital Universitario de La Princesa as lead sponsor.

NCT NCT03124199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03124199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rifaximin Associated With Classic Triple Therapy (Inhibitor of Proton Pump, Amoxicillin and Clarithromycin) for the Eradication of Helicobacter Pylori Infection
Lead sponsor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2014
Completion date
June 30, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infection due to helicobacter pylori (h. pylori)